Medicines for Europe

 

07.05.2026 - The Biosimilar Advantage: Powering patient access and industrial resilience

27.04.2026 - Leading manufacturers appeal in proceedings against discriminatory wastewater fees on medicine before European Court of Justice

16.04.2026 - Impact of the ongoing conflict in the Middle East on the supply of medicinal products to Europe

06.03.2026 - Reactive statement

20.02.2026 - Medicines for Europe response to the decision by the CJEU to deny legal standing based on procedural matters of admissibility and whether there is an individual concern

20.01.2026 - Parliament makes the Critical Medicines Act meaningful but significant risks to future access persist

07.01.2026 - Steffen Saltofte (Zentiva) named President of Medicines for Europe

15.12.2025 - Pharma legislation deal important for the future EU pharmaceutical industry but most importantly for access to medicine.

15.12.2025 - Environment omnibus and impact study fail to address huge flaws in Urban waste water treatment directive

15.10.2025 - European Commission risks repeating past mistakes in Urban Wastewater Treatment Directive cost study

24.09.2025 - Industry unites for a bold Critical Medicines Act that prioritises secure supply of medicines for patients

01.09.2025 - SANT Committee prioritises manufacturing competitiveness in draft report on the Critical Medicines Act

10.07.2025 - Medicines for Europe intervenes in legal challenge against Urban Wastewater Treatment Directive's EPR scheme

14.07.2021 - Slovenian Presidency Council of the EU - Priorities

22.04.2021 - European patients need improved access to biosimilar medicines

30.03.2021 - New report assesses progress on biosimilar medicine policies across Europe

17.03.2021 - Medicines for Europe statement to EUCO representatives in view of the meeting on Covid-19 and industrial policy

01.03.2021 - New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability

19.02.2021 - No further excuse to delay digital regulatory infrastructure for medicines after Covid-19 pandemic

19.02.2021 - A new medicines trade and health security agenda for the European Commission

25.11.2020 - Press release

17.09.2020 - Press release